Addressing gaps in treatment of AMD
February 14, 2021
Aleksandra Rachitskaya, MD, speaks on the current gaps in AMD treatment as well as ongoing retinal advancements to help address unmeet needs of patients.
© 2021 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
AMD Awareness
Rapid Readout: Angiopoietin-2 (Ang2) Inhibition in the Treatment of Diabetic Macular Edema and Exudative AMD.
March 22, 2021
Anat Loewenstein, MD, MHA, discusses data from the Angiogenesis, Exudation, and Degeneration 2021 Virtual Symposium on angiopoietin-2/VEGF-A dual inhibition in the management of diabetic macular edema and exudative age-related macular degeneration.
Emerging therapies for AMD management
February 07, 2021
Anat Loewenstein, MD, provides an update on the latest developments in emerging therapies for the management of age-related macular degeneration (AMD) and wet AMD.
Examining 3 major risk factors of AMD
February 05, 2021
Joshua Mali, MD, discusses the three major risk factors for developing age-related macular degeneration (AMD).
Learning the basics of age-related macular degeneration
February 03, 2021
Ian C. Han, MD, assistant professor in the Department of Ophthalmology and Visual Sciences, Institute for Vision Research, University of Iowa Hospital and Clinics, dives into the basics of age-related macular degeneration (AMD) and what patients need to know.